News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioElectronics Corporation Files With FDA for OTC Pre-Marketing Clearance


9/22/2009 9:35:40 AM

FREDERICK, Md., Sept. 22, 2009 (GLOBE NEWSWIRE) -- BioElectronics Corp. (Pink Sheets:BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) premarketing clearance for its ActiPatch(R) Therapy products. In this application BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy products for the indication of general pain relief relative for general musculoskeletal complaints.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES